FAMAR Acquires Homburg Sterile Manufacturing Site from MiP Pharma (MidEuropa-backed)
May 13, 2025
MidEuropa-backed portfolio company FAMAR signed an agreement to acquire a sterile manufacturing production site in Homburg (Saar), Germany from MiP Pharma. The addition expands FAMAR’s aseptic and lyophilised fill & finish capabilities and increases its European sterile manufacturing footprint to seven facilities, providing immediate capacity to serve international clients.
- Buyers
- MidEuropa, FAMAR
- Targets
- Homburg sterile manufacturing site (from MiP Pharma)
- Sellers
- MiP Pharma
- Platforms
- FAMAR
- Industry
- Pharmaceuticals
- Location
- Saarland, Germany
- Transaction Type
- Addon
Explore More
Build a buyer list for your deal
Find active buyers from recent acquisition patterns and move straight into outreach.